You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

clonal evolution

Showing 1 - 25 of 2,696
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GATA2 Gene Mutation Trial in France (Biological samples (blood and bone marrow samples).)

Not yet recruiting
  • GATA2 Gene Mutation
  • Biological samples (blood and bone marrow samples).
  • Angers, France
  • +16 more
Jul 31, 2023

Severe Aplastic Anemia Who Developed High Risk Clonal Evolution

Completed
  • Severe Aplastic Anemia
    • Bethesda, Maryland
      National Heart, Lung and Blood Institute (NHLBI)
    Apr 7, 2022

    MRD and Clonal Evolution in Waldenström's Macroglobulinemia and

    Active, not recruiting
    • Waldenstrom Macroglobulinemia
    • MRD and clonal evolution
    • Milano, MI, Italy
    • +13 more
    Nov 2, 2022

    ctDNA Methylation Sequencing for Myeloma

    Recruiting
    • Multiple Myeloma
    • plasma circulation DNA methylation sequencing
    • Tianjin, China
      Institute of Hematology and Blood Diseases Hospital Chinese Acad
    Oct 11, 2022

    Assessed With Liquid Biopsy in ICIs Treated NSCLC Patients

    Recruiting
    • Lung Neoplasms
    • +3 more
    • Observation
    • Shanghai, China
      Shanghai Chest Hospital
    Mar 14, 2022

    Primary Liver Cancer, Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma Trial in China (Observation)

    Recruiting
    • Primary Liver Cancer
    • +3 more
    • Observation
    • Beijing, Beijing, China
    • +4 more
    Jun 14, 2022

    Multiple Myeloma Trial in La Roche-sur-Yon, Nantes (No interventional study)

    Recruiting
    • Multiple Myeloma
    • No interventional study
    • La Roche-sur-Yon, France
    • +1 more
    Aug 5, 2021

    Bladder Cancer Trial in United States (Abemaciclib)

    Recruiting
    • Bladder Cancer
    • Tampa, Florida
    • +3 more
    Jul 27, 2022

    In Situ Clonal Heterogeneity in Prostatic Diagnostic Biopsies

    Recruiting
    • Prostate Cancer
    • Genetic Predisposition
    • clonal heterogeneity evaluation
    • Lugano, Ticino, Switzerland
      Alessandra Franzetti Pellanda
    Jul 19, 2022

    Dynamics of Clonal Evolution Leading to Recurrence in Prostate

    Recruiting
    • Prostate Cancer Recurrent
      • Sutton, Surrey, United Kingdom
        Royal Marsden Hospital
      Dec 22, 2020

      Ovarian Cancer Trial in Vandœuvre-lès-Nancy (Diagnostic Test)

      Recruiting
      • Ovarian Cancer
      • Diagnostic Test
      • Vandœuvre-lès-Nancy, France
        Institut de Cancerologie de Lorraine
      Mar 29, 2022

      Cancer for Patients Undergoing Transoral Robotic Surgery for

      Recruiting
      • Head & Neck Squamous Cell Cancer (HNSCC)
      • DNA Analysis
      • London, United Kingdom
        The Royal Marsden Hospital
      Dec 16, 2020

      Metastatic Oncogen-driven Cancer Trial in Villejuif (Biopsy)

      Recruiting
      • Metastatic Oncogen-driven Cancer
      • Biopsy
      • Villejuif, Val De Marne, France
        Gustave Roussy Cancer Campus Grand Paris
      Feb 23, 2021

      Assessed With Liquid Biopsy of NSCLC Patients in China

      Completed
      • Lung Neoplasms
      • +3 more
        • Guangzhou, Guangdong, China
        • +13 more
        Feb 3, 2020

        B Cells in High-risk CLL After Idelalisib-rituximab

        Withdrawn
        • Chronic Lymphocytic Leukemia
        • Biospecimen Collection
        • Philadelphia, Pennsylvania
          Abramson Cancer Center of the University of Pennsylvania
        Apr 12, 2019

        Myeloproliferative Tumor, Secondary Leukemia Trial (Multiomic characterization, In vitro drug screening)

        Not yet recruiting
        • Myeloproliferative Neoplasm
        • Secondary Leukemia
        • Multiomic characterization
        • In vitro drug screening
        • (no location specified)
        Aug 28, 2023

        Severe Aplastic Anemia, Single Lineage Cytopenias, T-LGL, Hypoplastic MDS Trial run by the National Heart, Lung, and Blood

        Not yet recruiting
        • Severe Aplastic Anemia
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Aug 23, 2023

        Steroid-refractory Diamond-Blackfan Anemia (DBA) Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Bitopertin)

        Not yet recruiting
        • Steroid-refractory Diamond-Blackfan Anemia (DBA)
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Apr 28, 2023

        Aplastic Anemia Trial in Beijing (Avatrombopag+CsA)

        Not yet recruiting
        • Aplastic Anemia
        • Beijing, China
          Peking union medical college hospital
        Aug 16, 2023

        Severe Aplastic Anemia Trial run by the NHLBI (Eltrombopag, Cyclosporine, Horse-Anti-thymocyte-Globulin)

        Recruiting
        • Severe Aplastic Anemia
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 27, 2023

        Genomic Evolution of Metastasis in Gastric Cancer

        Recruiting
        • Gastric Cancer
        • Metastasis
          • Ho Chi Minh City, Vietnam
            University Medical Center Ho Chi Minh City
          Apr 27, 2022

          Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC

          Recruiting
          • Non-small Cell Lung Cancer
            • Guanzhou, China
              Sun Yat-sen University Cancer Center
            Aug 11, 2023

            Non Small Cell Lung Cancer, EGFR Gene Mutation, Immune Checkpoint Inhibitor Trial in Jerusalem (concomitant TTFields treatment

            Not yet recruiting
            • Non Small Cell Lung Cancer
            • +2 more
            • concomitant TTFields treatment device to standard of care EGFR positive NSCLC treatment
            • concomitant TTFields treatment device to standard of care anti PD-1 NSCLC treatment
            • Jerusalem, Israel
              Shaare Zedek Medical Center
            Jan 22, 2023

            Shwachman-Diamond Syndrome, Shwachman-Diamond Syndrome-Like Trial in Aurora, Boston, Cincinnati

            Recruiting
            • Shwachman-Diamond Syndrome
            • Shwachman-Diamond Syndrome-Like
              • Aurora, Colorado
              • +3 more
              Sep 25, 2023

              Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving

              Recruiting
              • Non-small Cell Lung Cancer
              • Oligometastatic Disease
              • ctDNA testing and whole exome sequencing
              • Guangzhou, Guangdong, China
                Guangdong Lung Cancer Institute, Guangdong Provincial People's H
              Dec 5, 2022